Novelix Pharmaceuticals Ltd — Important, 09-04-2026: Company Update

Novelix Pharmaceuticals has reported a routine compliance update regarding its share dematerialisation process. The company confirmed that its Registrar and Share Transfer Agent verified all physical shares submitted for dematerialisation. These shares were properly cancelled and converted into electronic form, with depository records (NSDL and CDSL) updated promptly within 15 days. This ensures accurate and efficient management of shareholder records, reinforcing transparency and investor trust in the company's operational integrity related to its shares.